BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 29331074)

  • 1. Cryopyrin-associated periodic syndrome in early childhood can be successfully treated with interleukin-1 blockades.
    Eskola V; Pohjankoski H; Kröger L; Aalto K; Latva K; Korppi M
    Acta Paediatr; 2018 Apr; 107(4):577-580. PubMed ID: 29331074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MRP8 and MRP14, phagocyte-specific danger signals, are sensitive biomarkers of disease activity in cryopyrin-associated periodic syndromes.
    Wittkowski H; Kuemmerle-Deschner JB; Austermann J; Holzinger D; Goldbach-Mansky R; Gramlich K; Lohse P; Jung T; Roth J; Benseler SM; Foell D
    Ann Rheum Dis; 2011 Dec; 70(12):2075-2081. PubMed ID: 21908452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cryopyrin-associated periodic syndromes: diagnosis and management.
    Miyamae T
    Paediatr Drugs; 2012 Apr; 14(2):109-17. PubMed ID: 22335455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cryopyrin-associated periodic syndrome.
    Posch C; Kaulfersch W; Rappersberger K
    Pediatr Dermatol; 2014; 31(2):228-31. PubMed ID: 22891689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cryopyrin-associated periodic syndromes].
    Quartier P; Rodrigues F; Georgin-Lavialle S
    Rev Med Interne; 2018 Apr; 39(4):287-296. PubMed ID: 29111302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [CAPS treatment].
    Jiménez Treviño S; Ramos Polo E
    Med Clin (Barc); 2011 Jan; 136 Suppl 1():29-33. PubMed ID: 21596184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neonatal urticaria: Could it be CAPS?
    Cutts L; Parslew R; Eustace K
    Pediatr Dermatol; 2018 Nov; 35(6):e420-e421. PubMed ID: 30187963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological treatment options for cryopyrin-associated periodic syndromes.
    Landmann EC; Walker UA
    Expert Rev Clin Pharmacol; 2017 Aug; 10(8):855-864. PubMed ID: 28586272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current treatment recommendations and considerations for cryopyrin-associated periodic syndrome.
    Koné-Paut I; Galeotti C
    Expert Rev Clin Immunol; 2015; 11(10):1083-92. PubMed ID: 26312542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anakinra for cryopyrin-associated periodic syndrome.
    Koné-Paut I; Galeotti C
    Expert Rev Clin Immunol; 2014 Jan; 10(1):7-18. PubMed ID: 24308832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-1 blockade in autoinflammatory syndromes.
    Jesus AA; Goldbach-Mansky R
    Annu Rev Med; 2014; 65():223-44. PubMed ID: 24422572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cryopyrin-associated periodic syndrome: an update on diagnosis and treatment response.
    Yu JR; Leslie KS
    Curr Allergy Asthma Rep; 2011 Feb; 11(1):12-20. PubMed ID: 21104172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cryopyrin-associated periodic syndrome.
    Giat E; Lidar M
    Isr Med Assoc J; 2014 Oct; 16(10):659-61. PubMed ID: 25438464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of rheumatic diseases: current status and future prospective. Topics: III. Biological drugs; 4. Interleukin-1 inhibitor].
    Yamasaki S; Kawakami A
    Nihon Naika Gakkai Zasshi; 2011 Oct; 100(10):2985-90. PubMed ID: 22175142
    [No Abstract]   [Full Text] [Related]  

  • 15. Successful Treatment of CINCA/NOMID Syndrome with Interleukin-1 Blockade.
    Macejová Z; Vargová V; Matejka M; Szekanecz Z
    Isr Med Assoc J; 2015 Jun; 17(6):389-91. PubMed ID: 26234003
    [No Abstract]   [Full Text] [Related]  

  • 16. Severe cryopyrin-associated periodic syndrome first characterized by early childhood-onset sensorineural hearing loss - Case report and literature review.
    Hui A; Johnson LB; Greemberg R; Penney L; Ramsey SE
    Int J Pediatr Otorhinolaryngol; 2019 May; 120():68-72. PubMed ID: 30772614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cryopyrin-associated periodic syndromes: background and therapeutics.
    Kubota T; Koike R
    Mod Rheumatol; 2010 Jun; 20(3):213-21. PubMed ID: 20140476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neonatal treatment of CINCA syndrome.
    Paccaud Y; Berthet G; Von Scheven-Gête A; Vaudaux B; Mivelaz Y; Hofer M; Roth-Kleiner M
    Pediatr Rheumatol Online J; 2014; 12():52. PubMed ID: 25584041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful management of cryopyrin-associated periodic syndrome with canakinumab in infancy.
    Kanariou M; Tantou S; Varela I; Raptaki M; Petropoulou C; Nikas I; Valari M
    Pediatrics; 2014 Nov; 134(5):e1468-73. PubMed ID: 25349319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Update in interleukin-1 inhibition].
    de Boysson H
    Rev Med Interne; 2012 Apr; 33(4):235-7. PubMed ID: 22360831
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.